Trump tariffs in focus for global traders

Shares of Brighton Pier Group plummeted 59% by 10:40 a.m. U.K. time, after the company proposed delisting its stock.

The group — which owns multiple businesses across Britain, including Brighton Palace Pier on the U.K.’s south coast, minigolf sites and bars — announced Wednesday that it wanted to remove its shares from London’s FTSE AIM index at a rate of 25 pence ($0.32) per share to go private.

It has traded as a public company since 2013.

— Chloe Taylor

British computing startup Raspberry Pi reported a 57% drop in profit for the fiscal year 2024, in the company’s first earnings report since its London listing.

Pre-tax profits at the firm sank to $16.3 million — less than half the $38.2 million of profit it reported a year earlier. Full-year revenue also slipped, dropping about 2% year-over-year to $259.5 million.

Raspberry Pi is best known for manufacturing tiny single-board computers. It was established by CEO Eben Upton with the aim of making computing more accessible to young people.

Raspberry Pi’s computers can be used to power a whole range of uses. While they initially gained traction with hobbyists, today the firm is targeting large industrial players with its products.

The company went public in June 2024, in an initial public offering that raised £166 million ($214.6 million). Shares of the company — which have rallied over 80% from their IPO price — were up about 9% Wednesday.

Jacob Pedersen, head of equity research at Sydbank, told CNBC’s “Squawk Box Europe” on Wednesday that a trade war could dampen the ability of pharmaceutical companies to invest and earn money in the future, noting that tariffs were a new challenge for the sector.

— Chloe Taylor

The rollout of U.S. President Donald Trump’s tariffs regime is dampening sentiment on the dollar and prompting investors to look elsewhere for their foreign exchange trades, strategists told CNBC.  

Market watchers said they see potential upside for the euro, the British pound and Australia and New Zealand’s currencies.

Read the full story here.

— Chloe Taylor

Uncertainty may keep having a “spook effect” on markets even after U.S. President Donald Trump’s highly anticipated tariff announcement on Wednesday, Zoe Gillespie, chartered wealth manager at RBC Brewin Dolphin, told CNBC’s “Squawk Box Europe” on Wednesday.

“The danger is we don’t get much clarity for a long period of time … that could delay any peak bottom signals,” she said.

Gillespie said it was unlikely that full details on tariffs would be announced Wednesday, with other unknowns including whether trade partners such as the European Union would announce retaliatory tariffs, and the impact on inflation and interest rates.

“It’s been really difficult because you’re trying to prepare for something you don’t really know the detail of… for sectors it’s whether there is a degree of supply chains globally, or whether at this stage you’re looking at more domestic-focused companies that are less reliant on that. The service sector is another unknown as well,” she said.

— Jenni Reid

The European Central Bank has authorized Credit Agricole to raise its stake in Italian lender Banco BPM up to 19.9%, the French bank said Wednesday.

The ECB’s permission is a prerequisite for stakeholders to increase their position in a lender within the European Union past certain thresholds.

Credit Agricole on Wednesday disclosed it has gained a 9.9% stake in Banco BPM through derivatives since the fourth quarter of last year. It plans to exercise physical delivery of Banco BPM shares underlying that position and bring its holding to 19.8% of the Italian lender’s share capital.

“Crédit Agricole S.A. does not intend to launch a public offer for the capital of Banco BPM,” the French bank said. Banco BPM has already drawn the takeover sights of Italian rival UniCredit, which earlier on Wednesday revealed Italian regulators had authorized its offer document.

— Ruxandra Iordache

European stock markets opened lower Wednesday, with the Stoxx 600 index down 0.36% at 8:04 a.m. in London.

France’s CAC 40 and Germany’s DAX were both down around 0.35%, while the U.K.’s FTSE 100 fell 0.18%.

The Trump administration has guided that it will impose “maximum” reciprocal tariffs on trading partners on April 2, but the scale of the upside scenario is still to be gauged, Florian Ielpo, head of macro at Lombard Odier, told CNBC on Wednesday.

Ielpo said that according to his calculations, markets were pricing an effective tariff rate of between 6% and 10%, accounting for elements like import levels and exemptions.

“Markets are ready for that, they’ve been discounting the immediate effect of that — not the long-term, forward effect of that because it’s very difficult to know,” Ielpo said.

“The worst-case scenario is probably something in the region of 17%, which would be the largest increase in tariff duties we would have seen in 125 years of tariff data. For that, the Vix [Volatility Index] is clearly not high enough.”

“The key message for markets is rather than looking at sectors, [look at] the overall level of tariffs and the scale of magnitude with which they will be applied,” he added.

— Jenni Reid

Italian securities regulator Consob on Wednesday approved the document of UniCredit‘s takeover bid for Italian domestic peer Banco BPM, UniCredit said in a release.

The offer, which has been greenlit for a tender period between April 28 and June 23, entitles holders of each Banco BPM share to 0.175 newly issued UniCredit ordinary shares with regular dividend rights.

On the footsteps of building and increasing a surprise stake in Commerzbank late last year, UniCredit unexpectedly launched a $10.5 billion takeover offer for Banco BPM in November. Banco BPM at the time responded that the bid did not reflect its profitability and potential for further value creation.

— Ruxandra Iordache

Europe’s pharmaceutical sector is bracing for the potential impact of U.S. tariffs as hopes of an industry-wide exemption by U.S. President Donald Trump fade.

The pharmaceutical industry has until now been exempt from trade levies, but Trump confirmed last week that he would soon impose tariffs on the sector.

Drugmakers are now lobbying the president for a phased approach to duties on imports to the U.S., Reuters reported Tuesday, citing four sources familiar with the discussions. The sources said the levies may not be announced Wednesday but were likely inevitable.

Read the full story here.

— Karen Gilchrist

European markets are expected to open lower Wednesday as global traders prepare for U.S. President Donald Trump’s trade tariffs.

The U.K.’s FTSE 100 index is expected to open 24 points lower at 8,558, Germany’s DAX down 38 points at 22,501, France’s CAC 4 points lower at 7,872 and Italy’s FTSE MIB 74 points lower at 37,977, according to data from IG. 

There are no major data releases Wednesday. Earnings are set to come from Raspberry Pi.

— Holly Ellyatt

White House aides have drafted a proposal that would levy tariffs of roughly 20% on most imports, The Washington Post reported Tuesday.

The report cited three people familiar with the matter. It also said White House advisors cautioned that several options are still on the table, meaning the 20% tariffs may not come to pass. Another plan being considered is the country-by-country “reciprocal” approach, according to the Post.

The report comes a day before April 2, when President Donald Trump is set to announce his larger plans for global trade. The date has loomed over Wall Street, where stocks have been struggling in part due to uncertainty around rapidly changing global trade policy.

Read the full story here

— Jesse Pound